What's New

Last Posted: May 31, 2023

• Cancer Screening Experiences of Black Breast and Ovarian Cancer Patients and Family Members.
  Abigail Rousseau et al. J Community Health 2023 1-7
• Cost-Effectiveness Analysis of MammaPrint to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer.
  Marianne Luyendijk et al. Pharmacoeconomics 2023
• Designing a Dyad-Based Digital Health Intervention to Reduce Sedentary Time in Black Breast Cancer Survivors and Their First-degree Relatives: Human-Centered Design Study.
  Meghan Blazey et al. JMIR Form Res 2023 7e43592
• Factors predicting BRCA1/2 pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis.
  Giovanni Innella et al. J Clin Pathol 2023
• Prediction of breast cancer risk for sisters of women attending screening.
  Xinhe Mao et al. J Natl Cancer Inst 2023 5
• Independent evaluation of a multi-view multi-task convolutional neural network breast cancer classification model using Finnish mammography screening data.
  A Isosalo et al. Comput Biol Med 2023 161107023
• Predicting second breast cancer among women with primary breast cancer using machine learning algorithms, a population-based observational study.
  Maria-Eleni Syleouni et al. Int J Cancer 2023
• The Role of the Surgeon in the Germline Testing of the Newly Diagnosed Breast Cancer Patient.
  Stephanie Schick et al. Curr Oncol 2023 30(5) 4677-4687
• Clinical evaluation of a deep learning segmentation model including manual adjustments afterwards for locally advanced breast cancer.
  Nienke Bakx et al. Tech Innov Patient Support Radiat Oncol 2023 26100211
• Profiling of pharmacogenomic variants in CYP2D6 and DPYD in indigenous Arab breast cancer patients.
  Abdullah Alsulaiman et al. Pharmacogenomics 2023
• Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer: Implications for Guidance and Reimbursement.
  Dario Trapani et al. JCO Oncol Pract 2023 OP2200731
• Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
  Xuan Chen et al. JAMA Oncol 2023
• Breast cancer risk prediction combining a convolutional neural network-based mammographic evaluation with clinical factors.
  Alissa Michel et al. Breast Cancer Res Treat 2023
• Uptake of genetic testing among patients seeking cancer genetic counseling in Taiwan.
  Su-Ying Fang et al. J Genet Couns 2023
• Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome.
  Po-Han Lin et al. J Gynecol Oncol 2023
• Pivotal Role of Genetic Counselors in the Uptake of Germline Genetic Testing in Non-Metastatic Breast Cancer and the Impact of Testing on Surgical Decision Making.
  Richard A Erali et al. Am Surg 2023 31348231175097
• Effect on Germline Mutation Rate in a High-Risk Chinese Breast Cancer Cohort after Compliance with The National Comprehensive Cancer Network (NCCN) 2023 v.1 Testing Criteria.
  Ava Kwong et al. Cancers (Basel) 2023 15(9)
• Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients.
  Jingkun Qu et al. J Clin Med 2023 12(9)
• Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients
  J Henkel et al, AJHG, May 16, 2023
• Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.
  Ash Kieran Clift et al. BMJ 2023 381e073800
• Risk prediction models for breast cancer-related lymphedema: A systematic review and meta-analysis.
  Aomei Shen et al. Eur J Oncol Nurs 2023 64102326
• Update on the relationship between the SLC4A7 variant rs4973768 and breast cancer risk: a systematic review and meta-analysis.
  Yuhui Zhou et al. J Int Med Res 2023 51(4) 3000605231166517
• Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.
  Luiza Perez et al. Gynecol Oncol 2023 173106-113
• Clinical utility of polygenic risk scores: a critical 2023 appraisal
  S Koch et al, J Comm Genetics, May 3, 2023
• An Overview of the Use of Precision Population Medicine in Cancer Care: First of a Series.
  Johnny Yang et al. Cureus 2023 15(4) e37889
• Personalized prediction of one-year mental health deterioration using adaptive learning algorithms: a multicenter breast cancer prospective study.
  Konstantina Kourou et al. Sci Rep 2023 13(1) 7059
• Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab.
  Coralia Bueno-Muiño et al. JAMA Oncol 2023 4
• Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab.
  Adrienne G Waks et al. JAMA Oncol 2023 4
• Identification of key breast features using a neural network: applications of machine learning in the clinical setting of Plastic Surgery.
  Nitzan Kenig et al. Plast Reconstr Surg 2023
• Familial aggregation of early-onset cancers in early-onset breast cancer families.
  Jasmiina N J Rantala et al. Int J Cancer

More